You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
濟民製藥(603222.SH):邵品回購新友誼醫院84.49%股權
格隆匯 06-09 18:04

格隆匯6月9日丨濟民製藥(603222.SH)公佈,鑑於新友誼醫院2018年、2019年和2020年實際累計扣非淨利潤總額低於當年承諾的累計扣非淨利潤總額,公司要求邵品回購公司持有的新友誼醫院84.49%股權,回購款合計1.3596億元。據此,各方簽署了《股權回購協議》和《保證合同》,本次交易完成後,公司不再持有新友誼醫院股權。

此外,鑑於公司收購新友誼醫院後,新友誼醫院與鄆城縣人民政府簽訂了《鄆城新友誼醫院南擴建設項目意向書》,並支付了部分土地熟化成本。公司同意,待新友誼醫院取得該土地使用權後,可選擇將該土地使用權轉讓給公司,轉讓價格以具有證券期貨業務資格的評估機構出具的相關評估報吿載明的評估價值為依據,由雙方協商確定。後期,若新友誼醫院選擇將該土地使用權轉讓給公司,公司將採取多種措施確保收回不低於該金額的股權回購款,公司將該土地再行處置時,將面臨一定的價格波動風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account